Phase I study of selinexor, ixazomib and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
- Resource Type
- Source
- Clin Lymphoma Myeloma Leuk
- Subject
Oncology Cancer Research medicine.medical_specialty business.industry Low dose MEDLINE Hematology Article Ixazomib Phase i study Clinical trial chemistry.chemical_compound Text mining chemistry Internal medicine medicine In patient business Dexamethasone medicine.drug - Language
- English